Use of a proteomic approach to link pyruvate kinase M2 expression to oxaliplatin resistance in colorectal cancer patients and human cell lines

被引：0
|
作者：
Gines, A.
Martinez-Balibrea, E.
Plasencia, C.
Martinez-Cardus, A.
Musulen, E.
Neamati, N.
Manzano, J. L.
Abad, A.
机构：
[1] Hosp Germans Trias & Pujol ICO Badalona, Badalona, Spain
[2] Univ So Calif, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.4121
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4121
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Upregulation of pyruvate kinase M2 expression by fatty acid synthase contributes to gemcitabine resistance in pancreatic cancer
    Tian, Shenghua
    Li, Pingping
    Sheng, Shi
    Jin, Xin
    ONCOLOGY LETTERS, 2018, 15 (02) : 2211 - 2217
  • [22] Prognostic value of plasmatic tumor M2 pyruvate kinase and carcinoembryonic antigen in the survival of colorectal cancer patients
    Fatela-Cantillo, Daniel
    Fernandez-Suarez, Antonio
    Marin Moreno, Miguel Alonso
    Puente Gutierrez, Juan Jesus
    Diaz Iglesias, Jose Miguel
    TUMOR BIOLOGY, 2012, 33 (03) : 825 - 832
  • [23] DIAGNOSTIC VALUE OF TUMOR M2 PYRUVATE KINASE IN PATIENTS WITH LUNG CANCER
    Aslankara, Asuman
    Ortakoylu, Mediha Gonenc
    Bahadir, Ayse
    Alkan, Figen
    Caglar, Emel
    Uzun, Hafize
    Korkmaz, Gulcan
    Urer, Halidenur
    RESPIROLOGY, 2013, 18 : 23 - 23
  • [24] Measurement of fecal pyruvate kinase type M2 (Tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls
    Hardt, PD
    Toepler, M
    Ngoumou, B
    Rupp, J
    Kloer, HU
    ANTICANCER RESEARCH, 2003, 23 (2A) : 851 - 853
  • [25] Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer
    P D Hardt
    S Mazurek
    M Toepler
    P Schlierbach
    R G Bretzel
    E Eigenbrodt
    H U Kloer
    British Journal of Cancer, 2004, 91 : 980 - 984
  • [26] Tumor type M2 pyruvate kinase expression in metastatic renal cell carcinoma
    J. Roigas
    S. Deger
    J. Schroeder
    A. Wille
    I. Turk
    B. Brux
    K. Jung
    D. Schnorr
    S. A. Loening
    Urological Research, 2003, 31 : 358 - 362
  • [27] Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer
    Hardt, PD
    Mazurek, S
    Toepler, M
    Schlierbach, P
    Bretzel, RG
    Eigenbrodt, E
    Kloer, HU
    BRITISH JOURNAL OF CANCER, 2004, 91 (05) : 980 - 984
  • [28] Tumor type M2 pyruvate kinase expression in metastatic renal cell carcinoma
    Roigas, J
    Deger, S
    Schroeder, J
    Wille, A
    Turk, I
    Brux, B
    Jung, K
    Schnorr, D
    Loening, SA
    UROLOGICAL RESEARCH, 2003, 31 (06): : 358 - 362
  • [29] The Clinicopathological and Prognostic Relevance of Pyruvate Kinase M2 and pAkt Expression in Breast Cancer
    Benesch, Carina
    Schneider, Christine
    Voelker, Hans-Ullrich
    Kapp, Michaela
    Caffier, Hans
    Krockenberger, Mathias
    Dietl, Johannes
    Kammerer, Ulrike
    Schmidt, Melanie
    ANTICANCER RESEARCH, 2010, 30 (05) : 1689 - 1694
  • [30] THE CLINICOPATHOLOGICAL AND PROGNOSTIC RELEVANCE OF PYRUVATE KINASE M2 AND PAKT EXPRESSION IN BREAST CANCER
    Benesch, C.
    Schneider, C.
    Voelker, H. -U.
    Kapp, M.
    Caffier, H.
    Dietl, J.
    Kammerer, U.
    Schmidt, M.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4021 - 4022
12345